These findings suggest that renalase regulates hepatic lipid metabolism through the Akt–Srebf1 pathway, and its deficiency attenuates TG accumulation, suggesting that renalase may modulate early hepatic lipid deposition that progresses toward MASLD. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.